Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®

Clinical trial NCT00362427 · COMPLETED

Trial details

NCT number: NCT00362427
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diphtheria Pertussis Polio Hepatitis B Tetanus

Start date: 2006-08-01
Primary completion: 2009-02-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.